Professional Documents
Culture Documents
Epidemiology
Malaria
Presented by Daniel Ansong
Dept of Paediatrics
90 90% of malaria death occurs in sub 3000 death per day Prevalence in Ghana?
Saharan Africa
every year
Total
05/11/53
Diagnosis
Laboratory Clinical
Laboratory Diagnosis
Malaria Diagnostic Procedure
Thin and Thick film using Giemsa Staining Buffy coat preparation of concentrate mps Use of Rapid Immunodiagnostic strip test
Malaria positivity 1-10 parasites per 100 high power fields (HPF) + 11-100 Parasites per 100 HPF 11 ++ ++ 1-10 parasites in every HPF +++ More than 10 parasites per HPF ++++
Presentation
Mild Severe
05/11/53
Anaemia
Striking contrast between the palm of of a Kenyan child with anaemia, and that of his mother. Severe anaemia is of is the leading cause of of death in in children with m a l a ri a .
The sludging hypothesis (High proportion The permeability hypothesis Mechanical hypothesis Immunological hypothesis
of parasitized RBC in organs)
Severe malaria
Clinical signs suggestive of severe malaria
Haematological indices Hb <5.0g/dl PCV <15 15 Biochemical indices Blood Lactate level >5 mmol/l Blood Glucose of < 2.2 mmol/l Abnormal liver function Abnormal Renal function
05/11/53
Severe malaria
Clinical indices Prostration Inability to sit without support Inability to suck Inability to stand and walk without support Respiratory distress Haemoglobinuria Convulsion Blantyre coma score of <2
Group 2: Group 3:
Children with a haemoglobin level <5g/dl or a PCV <15 15% Children with 2 or more convulsions within a 24 hours period Children who require parentral treatment because of persistent vomiting
but who lack any specific clinical or laboratory features or group 1 or 2.
Severe malaria
Clinical indices
Prostration Impaired consciousness Multiple convulsions Circulation collapse Pulmonary oedema Abnormal bleeding Jaundice Haemoglobinuria Severe anaemia
Verbal response
Eye movements
Cerebral malaria Malaria with Renal failure Malaria associated impaired vision Malaria associated with ataxic gait Malaria associated with hearing loss Malaria with gram negative sepsis Hyper-reactive malaria syndrome HMS (Tropical splenomegaly syndrome) TSS Burkitts lymphoma
05/11/53
05/11/53
Complications of malaria
Cerebral malaria Definition: Patients unable to localized a painful stimulus (Blantyre coma scale of <=2 with malaria parasite and no other <= cause of neuropathy.
Cerebral malaria Malaria with Renal failure Malaria associated impaired vision Malaria associated with ataxic gait Malaria associated with hearing loss Malaria with gram-negative sepsis Hyper-reactive malaria syndrome HMS (Tropical splenomegaly syndrome) TSS Burkitts lymphoma
Cerebral malaria
A child with cerebral malaria, exhibiting severe opisthotonic (extensor) posturing. Between 10% to 10 to 20 20% of of children with cerebral malaria die, while approximately 7% are left with n e u ro l o g i c a l s e q u e l a e .
05/11/53
Spleen of a least 10 cm Long-term residence in malarious area Raised serum IgM Response to anti-malaria drugs Minor Criteria Liver biopsy showing hepatitic sinusoidal lymphocytosis Normal immune response to antigen challenge Normal phytohaemagglutination response Hypersplenism Lymphocyte proliferation Familial occurrence
Major Criteria
Management of Malaria
Objective behind the management of malaria To provide prompt treatment To reduce burden of parasitaemia To identify complications and respond appropriately and
promptly To minimizes the extent of complications To prevent infections
Clinical Malaria
Parenteral medication
05/11/53
Treatment of Malaria
are vomiting will require parentral treatment at least during the initial phase of management.
Treatment of malaria
Quinine
Treatment of Malaria
Side effect of Quinine
Currently the most widely used drug in the management of severe Dose regime 20 20mg/kg body weight as a start dose (Deep
falciparum malaria. intramuscular injection. Followed by maintenance dose of 10 10mg/kg body weight after 12 12hours and subsequently 12 12hours interval till patient can tolerate oral medication Oral quinine is given at 10 10mg/kg body weight (3X daily ) for the additional days. Maximum of 7days is allowed. IV-quinine is recommended but requires strict monitoring IV
Severe life threatening toxicity are rare Cinchonism-When plasma concentration is more than 5mg/L. Characterized by Tinnitus, high tone deafness, nausea, uneasiness, malaise and blurring of vision. Vomiting is likely if core temperatures are high.- Not and indication for stopping treatment
2. 2. 3. 3 . 4. 4.
Hypotension, Myocardial conduction disturbances blindness, deafness, and coma is associated with plasma concentration below 20 20mg/L Hypoglycaemia-Due to hyper-Insulinaemia Thrombocytopenia, coombs-positive haemolytic anaemia, haemolytic uraemic Syndrome
Treatment of malaria C hl o r o q ui ne
Drug Resistance
multiply or to survive in the presence of concentrations of a drug that normally destroy parasites of the same species or prevent their multiplication. Levels of Resistance: RI RI-Following treatment, parasitaemia clears but a recrudescence occurs. RII Following treatment, there is a reduction but not a clearance of parasitaemia RIII-Following treatment there is no reduction of parasitaemia
Amodiaquine Amodiaquine may be a useful substitute for chloroquine when oral Amodiaquine is rapidly and extensively converted to a
treatment is required. Parentral formulation is not available pharmacologically active metabolite, des-ethylamodiaquine, following oral administration, ant it seems that this metabolite is responsible for most of the antimalaria activity.
05/11/53
Chemo-prophylaxis
Chloroquine Progaunil Mefloquine
Vaccine
Thank you
Assignment
Write briefly on malaria preventive
initiatives in sub-Saharan Africa (Maximum of 2 pages)